Skip to main content
PMC home page
American Journal of Public Health logoLink to American Journal of Public Health
. 1998 Jun;88(6):876–879. doi: 10.2105/ajph.88.6.876

Health benefits and risks of reporting HIV-infected individuals by name.

G N Colfax 1, A B Bindman 1
PMCID: PMC1508234  PMID: 9618612

Abstract

With more treatment options emerging for human immunodeficiency virus (HIV) infection, the policy of reporting HIV-infected individuals by name merits reevaluation. This paper reviews the benefits and risks of name reporting of persons infected with HIV. Public health departments have linked name reporting with medical referrals, risk reduction counseling, and partner notification programs. Yet some studies indicate that people are less likely to be tested for HIV infection when name reporting is implemented. Whether name reporting actually improves individual or public health, therefore justifying the increased risk of loss of confidentiality and possibly reduced testing rates, remains unknown. The lack of health outcome data on name reporting allows beliefs rather than facts to dominate debate about this policy. Before this practice is more widely adopted, a determination should be made as to whether the potential benefits of name reporting outweigh the risks.

Full text

PDF
876

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bayer R., Fairchild-Carrino A. AIDS and the limits of control: public health orders, quarantine, and recalcitrant behavior. Am J Public Health. 1993 Oct;83(10):1471–1476. doi: 10.2105/ajph.83.10.1471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Buehler J. W., Berkelman R. L., Stehr-Green J. K. The completeness of AIDS surveillance. J Acquir Immune Defic Syndr. 1992;5(3):257–264. [PubMed] [Google Scholar]
  3. Constant-Desportes M., Guelpa-Lauras C. C., Carolina J. C., Léoture A., Grosset J. H., Sansarricq H. A case of relapse with drug-susceptible M. leprae after multidrug therapy. Int J Lepr Other Mycobact Dis. 1991 Jun;59(2):242–247. [PubMed] [Google Scholar]
  4. Fehrs L. J., Fleming D., Foster L. R., McAlister R. O., Fox V., Modesitt S., Conrad R. Trial of anonymous versus confidential human immunodeficiency virus testing. Lancet. 1988 Aug 13;2(8607):379–382. doi: 10.1016/s0140-6736(88)92846-2. [DOI] [PubMed] [Google Scholar]
  5. Fordyce E. J., Sambula S., Stoneburner R. Mandatory reporting of human immunodeficiency virus testing would deter blacks and Hispanics from being tested. JAMA. 1989 Jul 21;262(3):349–349. [PubMed] [Google Scholar]
  6. Frieden T. R., Fujiwara P. I., Washko R. M., Hamburg M. A. Tuberculosis in New York City--turning the tide. N Engl J Med. 1995 Jul 27;333(4):229–233. doi: 10.1056/NEJM199507273330406. [DOI] [PubMed] [Google Scholar]
  7. Hertz-Picciotto I., Lee L. W., Hoyo C. HIV test-seeking before and after the restriction of anonymous testing in North Carolina. Am J Public Health. 1996 Oct;86(10):1446–1450. doi: 10.2105/ajph.86.10.1446. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hirano D., England B., Hoff C., Helmstadter L., Boyd D., Fickes M., Doyle B., Kohrs J. Reporting HIV infections. J Acquir Immune Defic Syndr. 1994 Apr;7(4):417–418. [PubMed] [Google Scholar]
  9. Hirano D., Gellert G. A., Fleming K., Boyd D., Englender S. J., Hawks H. Anonymous HIV testing: the impact of availability on demand in Arizona. Am J Public Health. 1994 Dec;84(12):2008–2010. doi: 10.2105/ajph.84.12.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hoffman R. E., Wolf F. C., Wood R. C., Raevsky C., Vernon T. M. Confidential versus anonymous human immunodeficiency virus antibody testing. West J Med. 1990 Jan;152(1):75–75. [PMC free article] [PubMed] [Google Scholar]
  11. Hoxworth Tamara, Hoffman Richard, Cohn David, Davidson Arthur. Anonymous HIV testing: does it attract clients who would not seek confidential testing? AIDS Public Policy J. 1994 Winter;9(4):182–189. [PubMed] [Google Scholar]
  12. Judson F. N., Vernon T. M., Jr The impact of AIDS on state and local health departments: issues and a few answers. Am J Public Health. 1988 Apr;78(4):387–393. doi: 10.2105/ajph.78.4.387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kegeles S. M., Catania J. A., Coates T. J., Pollack L. M., Lo B. Many people who seek anonymous HIV-antibody testing would avoid it under other circumstances. AIDS. 1990 Jun;4(6):585–588. doi: 10.1097/00002030-199006000-00016. [DOI] [PubMed] [Google Scholar]
  14. Kegeles S. M., Coates T. J., Lo B., Catania J. A. Mandatory reporting of HIV testing would deter men from being tested. JAMA. 1989 Mar 3;261(9):1275–1276. doi: 10.1001/jama.1989.03420090039012. [DOI] [PubMed] [Google Scholar]
  15. Landis S. E., Schoenbach V. J., Weber D. J., Mittal M., Krishan B., Lewis K., Koch G. G. Results of a randomized trial of partner notification in cases of HIV infection in North Carolina. N Engl J Med. 1992 Jan 9;326(2):101–106. doi: 10.1056/NEJM199201093260205. [DOI] [PubMed] [Google Scholar]
  16. Levine C., Stein G. L. What's in a name? The policy implications of the CDC definition of AIDS. Law Med Health Care. 1991 Fall-Winter;19(3-4):278–290. doi: 10.1111/j.1748-720x.1991.tb01827.x. [DOI] [PubMed] [Google Scholar]
  17. McDonald A. M., Gertig D. M., Crofts N., Kaldor J. M. A national surveillance system for newly acquired HIV infection in Australia. National HIV Surveillance Committee. Am J Public Health. 1994 Dec;84(12):1923–1928. doi: 10.2105/ajph.84.12.1923. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Meyer P. A., Jones J. L., Garrison C. Z., Dowda H. Comparison of individuals receiving anonymous and confidential testing for HIV. South Med J. 1994 Mar;87(3):344–347. doi: 10.1097/00007611-199403000-00009. [DOI] [PubMed] [Google Scholar]
  19. Rahman M., Fukui T. Partner notification program and possibility of including it in the HIV prevention strategies in Japan. J Epidemiol. 1996 Sep;6(3):158–165. doi: 10.2188/jea.6.158. [DOI] [PubMed] [Google Scholar]
  20. Rosenblum L., Buehler J. W., Morgan M. W., Costa S., Hidalgo J., Holmes R., Lieb L., Shields A., Whyte B. M. The completeness of AIDS case reporting, 1988: a multisite collaborative surveillance project. Am J Public Health. 1992 Nov;82(11):1495–1499. doi: 10.2105/ajph.82.11.1495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Rutherford G. W., Woo J. M. Contact tracing and the control of human immunodeficiency virus infection. JAMA. 1988 Jun 24;259(24):3609–3610. [PubMed] [Google Scholar]
  22. Smith E., Rix B. A., Melbye M. Mandatory anonymous HIV surveillance in Denmark: the first results of a new system. Am J Public Health. 1994 Dec;84(12):1929–1932. [PMC free article] [PubMed] [Google Scholar]
  23. Steinbrook R. Battling HIV on many fronts. N Engl J Med. 1997 Sep 11;337(11):779–781. doi: 10.1056/NEJM199709113371109. [DOI] [PubMed] [Google Scholar]
  24. Wortley P. M., Chu S. Y., Diaz T., Ward J. W., Doyle B., Davidson A. J., Checko P. J., Herr M., Conti L., Fann S. A. HIV testing patterns: where, why, and when were persons with AIDS tested for HIV? AIDS. 1995 May;9(5):487–492. [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES